Summit Therapeutics
PulseAugur coverage of Summit Therapeutics — every cluster mentioning Summit Therapeutics across labs, papers, and developer communities, ranked by signal.
- 2026-09-29 funding AstraZeneca invested $2 billion in Summit Therapeutics to advance Akeso's drug ivonescimab. source
-
Global interest in Chinese biotech surges with major pharma deals
Global interest in Chinese biotech is rising, evidenced by significant deals involving major pharmaceutical companies. AstraZeneca is investing $2 billion in Summit Therapeutics, which is advancing Akeso's immunotherapy…
-
Akeso's Ivonescimab Outperforms AstraZeneca's Imfinzi in Cancer Trial
Chinese biopharmaceutical company Akeso announced that its immunotherapy drug, Ivonescimab, outperformed AstraZeneca's Imfinzi in a Phase 3 trial for biliary tract cancer. This trial, involving 682 patients, is the firs…
-
Elon Musk's $158B award highlights soaring CEO pay and widening gap
Executive compensation in 2025 saw significant increases, with Elon Musk leading the pack by an extraordinary margin due to a reinstated Tesla stock award valued at $158.4 billion. Excluding Musk, median CEO compensatio…